BashirAlHussein Profile Banner
Bashir Al Hussein Profile
Bashir Al Hussein

@BashirAlHussein

Followers
586
Following
812
Media
11
Statuses
201

Assistant Professor and Urologic Oncologist @WeillCornell - Former Urologic Oncology fellow @VUMChealth and Urology Resident @WeillCornell

New York, NY
Joined March 2009
Don't wanna be here? Send us removal request.
@BashirAlHussein
Bashir Al Hussein
2 years
Functional outcomes after contemporary #prostatecancer treatments through 10 yrs, stratified by disease prognosis - out now in @JAMA_current https://t.co/P5F5tLqbm4 @DanBarocas @WallisCJD @urogeek @KHoffmanMD @CaPsurvivorship @RuchikaTalwarMD @KoyamaTatsuki @VUMChealth (1/5)
4
39
127
@UrologyTimes
Urology Times
4 months
Bashir Al Hussein Al Awamlh, MD, MPH, (@BashirAlHussein) discusses the development of a tool to predict prostate cancer outcomes using patient-reported data. @WCMUrology https://t.co/JSTGCUXS4W
Tweet card summary image
urologytimes.com
The tool is designed as a patient-facing application that can be used both during clinic visits and independently at home.
0
5
9
@UrologyTimes
Urology Times
4 months
Data from a recent study showed that 1 in 6 men with GG1 prostate cancer ultimately had higher-risk disease when other clinical features were considered, indicating that biopsy grade alone may underestimate disease risk. @BashirAlHussein @jeshoag
urologytimes.com
Data showed that 1 in 6 men with GG1 prostate cancer ultimately had higher-risk disease when other clinical features were taken into account.
0
3
10
@WCMUrology
Weill Cornell Medicine Urology
4 months
Co-senior author, Dr. Al Hussein, and first author, Dr. Patel, discuss findings from their new study published in @JAMAOnc titled, "Grade Group 1 Prostate Cancer Outcome by Biopsy Grade and Risk Group." Learn more about the team's research by visiting: https://t.co/ujAtZiykMM
0
6
20
@RuchikaTalwarMD
Ruchika Talwar
8 months
Thrilled to share this labor of love just published in @JCO_ASCO exploring drivers behind cancer drug shortages and proposing actionable solutions ➡️ https://t.co/Y0eW8Ljtvj #HealthPolicy #Advocacy @VUMCDiscoveries @ASCO @urogeek
Tweet card summary image
ascopubs.org
2
9
36
@jeshoag
Jonathan Evan Shoag 🇮🇱🇺🇸
9 months
New paper from my group and @giladevrony’s! https://t.co/AGS3p55Qap Historically we measured new mutations in humans using trio studies (parents and offspring). This taught us that on average new mutations increase in offspring with paternal age. These trio studies showed
Tweet card summary image
nature.com
Nature Communications - Mutations accumulate with age in the male germline, and can lead to genetic diseases in offspring. Here, the authors collect from individuals sequential sperm samples...
4
10
36
@urotoday
UroToday.com
1 year
#CEASAR study reveals long-term quality of life outcomes for localized #ProstateCancer treatments. @DanBarocas @VUMCurology & @BashirAlHussein @WeillCornell discuss findings of this study which aims to enhance shared decision-making in treatment > https://t.co/Yht8IZYN0D
0
8
27
@CGaffMD
Christopher Gaffney
1 year
Honored to receive the Chairman’s Award for Excellence in Clinic Research @MSKCancerCenter surgery graduation. Not possible w/o exceptional mentorship from @BehfarEhdaieMD Howard Scher Matt Dallos @eugene_pietzak + support from @PCF_Science @UrologyCareFdn @UrologyMSK Ravetch Lab
9
5
63
@urotoday
UroToday.com
2 years
#CEASAR study reveals long-term quality of life outcomes for localized #ProstateCancer treatments. @DanBarocas @VUMCurology & @BashirAlHussein @WeillCornell discuss findings of this study which aims to enhance shared decision-making in treatment > https://t.co/Yht8IZYN0D
1
3
10
@UroOncJT
Jeff Tosoian, MD, MPH
2 years
For those that prefer watching to reading (i.e. everyone). Thanks for having me on! @urotoday @AndreaMiyahira
@urotoday
UroToday.com
2 years
Novel 18-gene urine test improves detection of clinically significant #ProstateCancer. @UroOncJT @VUMCurology joins @AndreaMiyahira @PCFnews to discuss this new tool in #PCa diagnosis and research published in @JAMAOnc > https://t.co/o7ZzRrIZmv @UMRogelCancer @VUMC_Cancer
0
6
24
@WCMUrology
Weill Cornell Medicine Urology
2 years
Join us in welcoming Dr. Bashir Al Hussein Al Awamlh (@BashirAlHussein) to @WeillCornell @nyphospital! We are so excited to have you on the team. To learn more about Dr. Al Hussein Al Awamlh and his expertise in the field of urologic oncology, visit https://t.co/VMLXaxcpTV
4
7
90
@VUmedicine
Vanderbilt School of Medicine
2 years
RESEARCH RECOGNITION: Bashir Al Hussein Al Awamlh, MD, a second-year MPH student on the Epidemiology Track, had his research on the side effects of prostate cancer treatment featured by the @NIH! Read the full piece: https://t.co/bHyRZpqlD7 #VandyMed #VandyMPH
0
2
19
@HemOncToday
HemOnc Today
2 years
Healio spoke with @BashirAlHussein about recent study findings showing that adverse events experienced by men with prostate cancer varied considerably based on the treatment they received and how oncologists can best counsel patients. Read more 👇 https://t.co/1JJZsbZzCB
Tweet card summary image
healio.com
Adverse events experienced by men with prostate cancer varied considerably based on the treatment they received, results of a 10-year follow-up study showed.The multicenter Comparative Effectiveness...
0
1
2
@BashirAlHussein
Bashir Al Hussein
2 years
Thank you Dr @KBibbinsDomingo and @JAMA_current for this opportunity! @DanBarocas @WallisCJD @VUMCurology
@KBibbinsDomingo
Kirsten Bibbins-Domingo
2 years
Functional Outcomes After Localized Prostate Cancer Treatment @BashirAlHussein @DanBarocas & colleagues https://t.co/WdPnyewi2m …one of our “top viewed” this week at JAMA
0
1
20
@Chris_Barbieri1
Chris Barbieri
2 years
So proud of @BashirAlHussein and looking forward to having him back at @WCMUrology building his research program! @WCMGUcancer @WCM_PCa_SPORE @WCMPopHealthSci
@JAMA_current
JAMA
2 years
In localized prostate cancer, radical prostatectomy was associated with worse urinary incontinence, but not worse sexual function, at 10-year follow-up. https://t.co/iv37vXpPS8
1
6
43
@RodriguezMDUrol
Dr.Larissa Rodriguez
2 years
Way to go Bashir! Proud of you and the team
@JAMA_current
JAMA
2 years
In localized prostate cancer, radical prostatectomy was associated with worse urinary incontinence, but not worse sexual function, at 10-year follow-up. https://t.co/iv37vXpPS8
1
1
21
@jeshoag
Jonathan Evan Shoag 🇮🇱🇺🇸
2 years
Amazing work by @BashirAlHussein!
@JAMA_current
JAMA
2 years
In localized prostate cancer, radical prostatectomy was associated with worse urinary incontinence, but not worse sexual function, at 10-year follow-up. https://t.co/iv37vXpPS8
1
2
13
@urogeek
Dave Penson
2 years
Great work, Bashir! Proud of you! Third CEASAR paper in JAMA. @DanBarocas you are the man!!!
@BashirAlHussein
Bashir Al Hussein
2 years
Functional outcomes after contemporary #prostatecancer treatments through 10 yrs, stratified by disease prognosis - out now in @JAMA_current https://t.co/P5F5tLqbm4 @DanBarocas @WallisCJD @urogeek @KHoffmanMD @CaPsurvivorship @RuchikaTalwarMD @KoyamaTatsuki @VUMChealth (1/5)
0
4
45
@DanBarocas
Daniel Barocas
2 years
@BashirAlHussein @JAMA_current @WallisCJD @urogeek @KHoffmanMD @CaPsurvivorship @RuchikaTalwarMD @KoyamaTatsuki @VUMChealth @PCFnews @AmerUrological @VUMC_Insights @VUMC_Cancer @VUMCepi @VUMCDiscoveries Such an honor to work with this amazing team. #prostatecancer is so tough on people. We hope that these data will ease some of the burden by helping people know what to expect and make more informed choices about management.
0
3
15
@BashirAlHussein
Bashir Al Hussein
2 years
Grateful to patients that participated in the CEASAR study, and for the mentorship of @DanBarocas & @urogeek @VUMCurology - We hope this work will support informed decision-making Next up ➡️ Personalized patient-facing prediction tool & 10 yr oncological outcomes (5/5)
0
0
7